Study S001978

Real-world Effectiveness and Dosing Patterns of Tirzepatide: A Multicentre Retrospective Observational Study in the Netherlands

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07504172
Acronym: TIRZ-DOSE-NL
Study type: OBSERVATIONAL
Status: NOT_YET_RECRUITING
Enrollment: 1700
Start: 2026-04-01
Primary completion: 2026-07-01
Lead sponsor: Radboud University Medical Center
Conditions: Overweight , Obesity; Obesity (Disorder)
Interventions: DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Weight change [Baseline-6 months]

Linked records (3)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0009032	A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults. McGowan B, Nature medicine	2025	Systematic review	PMID 41039116 DOI	registry reference BACKGROUND:41039116
R0017665	Tirzepatide for Obesity Treatment and Diabetes Prevention. Jastreboff AM, The New England journal of medicine	2025	Randomized trial	PMID 39536238 DOI	registry reference BACKGROUND:39536238
R0010987	Tirzepatide Once Weekly for the Treatment of Obesity. Jastreboff AM, The New England journal of medicine	2022	Randomized trial	PMID 35658024 DOI	registry reference BACKGROUND:35658024